BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30530780)

  • 1.
    Xiao W; Bharadwaj M; Levine M; Farnhoud N; Pastore F; Getta BM; Hultquist A; Famulare C; Medina JS; Patel MA; Gao Q; Lewis N; Pichardo J; Baik J; Shaffer B; Giralt S; Rampal R; Devlin S; Cimera R; Zhang Y; E Arcila M; Papaemmanuil E; Levine RL; Roshal M
    Blood Adv; 2018 Dec; 2(23):3526-3539. PubMed ID: 30530780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants.
    Shiozawa Y; Fujita S; Nannya Y; Ogawa S; Nomura N; Kiguchi T; Sezaki N; Kudo H; Toyama T
    Int J Hematol; 2024 Apr; 119(4):465-471. PubMed ID: 38424413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory characterization of the pediatric B/T subtype of mixed-phenotype acute leukemia: Report of a case series.
    Demina I; Mikhailova E; Zerkalenkova E; Semchenkova A; Roumiantseva J; Borkovskaya A; Matveev E; Abramov D; Konovalov D; Miakova N; Ponomareva N; Belkina J; Kondratchik K; Olshanskaya Y; Novichkova G; Karachunskiy A; Popov A
    Am J Clin Pathol; 2024 Mar; ():. PubMed ID: 38513276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia with mixed phenotype is characterized by stemness transcriptomic signatures and limited lineage plasticity.
    Galera P; Dilip D; Derkach A; Chan A; Zhang Y; Persuad S; Mishera T; Liu Y; Famulare C; Gao Q; Mata DA; Arcila M; Geyer MB; Stein E; Dogan A; Levine RL; Roshal M; Glass J; Xiao W
    medRxiv; 2023 Nov; ():. PubMed ID: 37961275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHF6 mutations in T-cell acute lymphoblastic leukemia.
    Van Vlierberghe P; Palomero T; Khiabanian H; Van der Meulen J; Castillo M; Van Roy N; De Moerloose B; Philippé J; González-García S; Toribio ML; Taghon T; Zuurbier L; Cauwelier B; Harrison CJ; Schwab C; Pisecker M; Strehl S; Langerak AW; Gecz J; Sonneveld E; Pieters R; Paietta E; Rowe JM; Wiernik PH; Benoit Y; Soulier J; Poppe B; Yao X; Cordon-Cardo C; Meijerink J; Rabadan R; Speleman F; Ferrando A
    Nat Genet; 2010 Apr; 42(4):338-42. PubMed ID: 20228800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHF6 Expression Levels Impact Human Hematopoietic Stem Cell Differentiation.
    Loontiens S; Dolens AC; Strubbe S; Van de Walle I; Moore FE; Depestel L; Vanhauwaert S; Matthijssens F; Langenau DM; Speleman F; Van Vlierberghe P; Durinck K; Taghon T
    Front Cell Dev Biol; 2020; 8():599472. PubMed ID: 33251223
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
    Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL.
    Improgo MR; Tesar B; Klitgaard JL; Magori-Cohen R; Yu L; Kasar S; Chaudhary D; Miao W; Fernandes SM; Hoang K; Westlin WF; Kim HT; Brown JR
    Br J Haematol; 2019 Mar; 184(6):925-936. PubMed ID: 30537114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis.
    Tamari R; Rapaport F; Zhang N; McNamara C; Kuykendall A; Sallman DA; Komrokji R; Arruda A; Najfeld V; Sandy L; Medina J; Litvin R; Famulare CA; Patel MA; Maloy M; Castro-Malaspina H; Giralt SA; Weinberg RS; Mascarenhas JO; Mesa R; Rondelli D; Dueck AC; Levine RL; Gupta V; Hoffman R; Rampal RK
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1142-1151. PubMed ID: 30625392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-lymphoid/myeloid mixed phenotype acute leukemia and early T-cell precursor lymphoblastic leukemia similarities with
    Noronha EP; Marques LVC; Andrade FG; Sardou-Cezar I; Dos Santos-Bueno FV; Zampier CDP; Terra-Granado E; Pombo-de-Oliveira MS
    Cancer Manag Res; 2019; 11():3933-3943. PubMed ID: 31118806
    [No Abstract]   [Full Text] [Related]  

  • 11. Panel-based next-generation sequencing facilitates the characterization of childhood acute myeloid leukemia in clinical settings.
    Ishida H; Iguchi A; Aoe M; Nishiuchi R; Matsubara T; Keino D; Sanada M; Shimada A
    Biomed Rep; 2020 Nov; 13(5):46. PubMed ID: 32934818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms and therapeutic implications of hypermutation in gliomas.
    Touat M; Li YY; Boynton AN; Spurr LF; Iorgulescu JB; Bohrson CL; Cortes-Ciriano I; Birzu C; Geduldig JE; Pelton K; Lim-Fat MJ; Pal S; Ferrer-Luna R; Ramkissoon SH; Dubois F; Bellamy C; Currimjee N; Bonardi J; Qian K; Ho P; Malinowski S; Taquet L; Jones RE; Shetty A; Chow KH; Sharaf R; Pavlick D; Albacker LA; Younan N; Baldini C; Verreault M; Giry M; Guillerm E; Ammari S; Beuvon F; Mokhtari K; Alentorn A; Dehais C; Houillier C; Laigle-Donadey F; Psimaras D; Lee EQ; Nayak L; McFaline-Figueroa JR; Carpentier A; Cornu P; Capelle L; Mathon B; Barnholtz-Sloan JS; Chakravarti A; Bi WL; Chiocca EA; Fehnel KP; Alexandrescu S; Chi SN; Haas-Kogan D; Batchelor TT; Frampton GM; Alexander BM; Huang RY; Ligon AH; Coulet F; Delattre JY; Hoang-Xuan K; Meredith DM; Santagata S; Duval A; Sanson M; Cherniack AD; Wen PY; Reardon DA; Marabelle A; Park PJ; Idbaih A; Beroukhim R; Bandopadhayay P; Bielle F; Ligon KL
    Nature; 2020 Apr; 580(7804):517-523. PubMed ID: 32322066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
    Orgel E; Alexander TB; Wood BL; Kahwash SB; Devidas M; Dai Y; Alonzo TA; Mullighan CG; Inaba H; Hunger SP; Raetz EA; Gamis AS; Rabin KR; Carroll AJ; Heerema NA; Berman JN; Woods WG; Loh ML; Zweidler-McKay PA; Horan JT;
    Cancer; 2020 Feb; 126(3):593-601. PubMed ID: 31661160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of Philadelphia chromosome in mixed phenotype acute leukemia (MPAL): A cancer registry analysis on real-world outcome.
    Qasrawi A; Ramlal R; Munker R; Hildebrandt GC
    Am J Hematol; 2020 Sep; 95(9):1015-1021. PubMed ID: 32419244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia.
    Porwit A; Béné MC
    Cytometry B Clin Cytom; 2019 May; 96(3):183-194. PubMed ID: 31033213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Leukemias of Ambiguous Lineage: Clarification on Lineage Specificity.
    Kurzer JH; Weinberg OK
    Surg Pathol Clin; 2019 Sep; 12(3):687-697. PubMed ID: 31352981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of PHF6 in Hematopoiesis and Hematologic Malignancies.
    Eisa YA; Guo Y; Yang FC
    Stem Cell Rev Rep; 2023 Jan; 19(1):67-75. PubMed ID: 36008597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia.
    Tsai HI; Wu Y; Huang R; Su D; Wu Y; Liu X; Wang L; Xu Z; Pang Y; Sun C; He C; Shu F; Zhu H; Wang D; Cheng F; Huang L; Chen H
    Acta Pharm Sin B; 2022 Apr; 12(4):1913-1927. PubMed ID: 35847518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 Fusion.
    Ma J; Liu YC; Voss RK; Ma J; Palagani A; Caldwell E; Rosikiewicz W; Cardenas M; Foy S; Umeda M; Wilkinson MR; Inaba H; Klco JM; Rubnitz JE; Wang L
    Leukemia; 2024 May; 38(5):981-990. PubMed ID: 38429501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.
    Kubota Y; Gu X; Terkawi L; Bodo J; Przychodzen BP; Awada H; Williams N; Gurnari C; Kawashima N; Aly M; Durmaz A; Mori M; Ponvilawan B; Kewan T; Bahaj W; Meggendorfer M; Jha BK; Visconte V; Rogers HJ; Haferlach T; Maciejewski JP
    Nat Commun; 2024 Feb; 15(1):1832. PubMed ID: 38418452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.